Type 2 Diabetes Patients Benefit From Bone Marrow Stem Cell Transplants

Type 2 diabetes patients who receive self-donated (autologous) bone marrow stem cells require less insulin, a new study revealed. The research, published in Cell Transplantation, was carried out in India and looked at the safety and efficacy of autologous transplanted bone marrow stem cells in patients with type 2 diabetes (TD2M)... via Health News from Medical News Today Read More Here..